I-BASE HIV TREATMENT BULLETINImportant note: Information in this article was accurate in June 2006. The state of the art may have changed since the publication date.
Click here to return to I-BASE main menu
DonateNow
Print this Article


Draft BHIVA immunisation guidelines online

HIV Treatment Bulletin - Vol. 7, No. 6, June 2006


Compared with HIV-seronegative individuals, HIV-seropositive persons may have an increased risk of infection or experience more severe disease following exposure to vaccine-preventable diseases. The positive impact of antiretroviral therapy on the natural history of HIV infection makes the formulation of HIV-specific immunisation guidelines important at this time.

These guidelines contain evidence-graded recommendations that can assist the judicious use of active and passive immunisation in HIV-infected adults as a cost-effective way of reducing the disease burden for individual patients while also providing a wider public health benefit.

The primary objective is to inform clinical practice, based on the best available evidence and expert consensus opinion at the time of development. Given the lack of controlled studies, the recommendations are often an expression of a consensus derived from descriptive studies, clinical experience and expert opinion.

The current draft will be revised following a period of consultation. Feedback on any aspect of the guidelines is strongly encouraged. To view the guidelines, please go to the BHIVA website

Please forward your comments to the BHIVA Secretariat at:
bhiva@bhiva.org

2006-06-10
IB060706-24


©2006. I-BASE HIV Treatment Bulletin. Permission to reproduce courtesy of HIV i-Base, Third Floor East, Thrale House, 44-46 Southwark Street, London SE1 1UN - T: +44 (0) 20 7407 8488 F: +44 (0) 20 7407 8489

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2006. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2006. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.